Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
New Drug Slashes Heart Attack, Stroke Risk in Diabetics | |
|
| |
A new drug may prevent heart attack risk in patients with type 2 diabetes, finds a research.
The revolutionary new treatment could help thousands of patients who do not respond to the commonly used first-line treatment, metformin, the Daily Express reported.
The revolutionary new treatment could help thousands of patients who do not respond to the commonly used first-line treatment, metformin, the Daily Express reported.
Metformin can become ineffective in the long term for many patients, according to an article published online in The Lancet.
Patients are then offered a class of drugs that is known as sulphonylureas in addition.
However, these drugs can lead to low blood sugar levels that is known as hypoglycaemia, and weight gain, putting patients at increased risk of heart attack and stroke.
The new drug, linagliptin, results in significantly less weight gain and also less hypoglycaemia, experts from Tubingen University Hospital, in Germany, has found.
Source-ANI
| |
|
|
More News on: Drug Toxicity, Clinical Trials - Different Phases of the trial , Bell’s Palsy, Diabetes - Self-Monitoring of Blood Glucose (SMBG), Diabetes and Exercise, Diet Lifestyle and Heart Disease, Mitral Valve Stenosis And Mitral Valve Replacement, Congenital Heart Disease, Signature Drug Toxicity, Stress and the Gender Divide
 Comment & Contribute
|
Related Links
Type 2 Diabetes
Globalization and changing lifestyles has made diabetes very common in developing countries so much so that India is known as the Diabetes Capital of ...
Diabetes - Essentials
Diabetes is a common malady that affects members of both the sexes. Efforts are made to manage the disease through user- friendly gadgets and by ...
Diabetes Type 2 - New Once a Day Drug Linagliptin Approved by FDA
The US Food and Drug Administration (FDA) recently approved linagliptin (Tradjenta) for improving blood glucose levels in adults with type ...
Drug Related News
Doctors Say Soaring Temperatures can Affect Quality of Pills
Extreme heat can affect medicines, say researchers. "Quality of medicines can deteriorate during summers because of high ...
Statin Use Ups Diabetes Risk
Use of atorvastatin and simvastatin may boost the risk of developing diabetes, suggests study published in BMJ. Statins are ...
Link Between Calcium Supplements and Longer Lifespan Identified
Intake of calcium supplements can help women live longer, says study published in Journal of Clinical Endocrinology & Metabolism (JCEM). ...
Experts Recommend US Approval of a New Merck Sleeping Pill
Independent panel of experts recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage ...
Common Drug for Depression Reduces Stress-related Heart Condition
Researchers at Duke Medicine have found that a drug commonly used to treat depression and anxiety may improve a stress-related heart condition in ...
New, Effective Sleeping Pill from Merck to Hit US Markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall asleep and stay asleep, say reviewers at the US Food and ...
- Health News Index
|
|
 | Quiz on Heart A quiz on heart to learn more about its functions. 
|
- News Quick Links
 |
Stroke
Complete Medindia Resources
|
| News Categories: |
| » | Targeting Cell ‘Power Plants’ Promising Approach for Prevention of Drug-Resistant Cancers |
| » | Non-Surgical Breast Cancer Therapy Trial Underway in Japan |
| » | New Technique can Detect Breast Cancer by Analyzing Urine Samples |
| » | Low Radiation Scans Help Identify Cancer in Earliest Stages: Study |
| » | Researchers Say Timing of Cancer Radiation Therapy May Minimize Hair Loss |
| More Cancer News | |
|
Ask an Expert
